{"transactions":[{"id":3374691,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-12T17:10:00.000Z","date":"2019-11-08","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":20250,"derivative":{"exercise_price":25.37,"expiration_date":"2023-03-05","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-19-056090","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119056090/doc4.xml","form_type":"4"}},{"id":3374690,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-12T17:10:00.000Z","date":"2019-11-08","kind":"exercise","acquired":false,"shares":14698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":14698},"source":{"system":"sec-edgar","filing":"0001209191-19-056090","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119056090/doc4.xml","form_type":"4"}},{"id":3374689,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-12T17:10:00.000Z","date":"2019-11-08","kind":"sale","acquired":false,"shares":19448,"price":45,"value":875160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":16061,"source":{"system":"sec-edgar","filing":"0001209191-19-056090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119056090/doc4.xml","form_type":"4"}},{"id":3374688,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-12T17:10:00.000Z","date":"2019-11-08","kind":"exercise","acquired":true,"shares":4750,"price":25.37,"value":120507.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":35509,"source":{"system":"sec-edgar","filing":"0001209191-19-056090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119056090/doc4.xml","form_type":"4"}},{"id":3374687,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-12T17:10:00.000Z","date":"2019-11-08","kind":"exercise","acquired":true,"shares":14698,"price":10.81,"value":158885.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":30759,"source":{"system":"sec-edgar","filing":"0001209191-19-056090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119056090/doc4.xml","form_type":"4"}},{"id":3499055,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T17:01:06.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":43.54,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-035126","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119035126/doc4.xml","form_type":"4"}},{"id":3499054,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-06T17:01:06.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2020, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":16061,"source":{"system":"sec-edgar","filing":"0001209191-19-035126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119035126/doc4.xml","form_type":"4"}},{"id":3499053,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-06T17:01:06.000Z","date":"2019-06-05","kind":"sale","acquired":false,"shares":4114,"price":43.5,"value":178959.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":11061,"source":{"system":"sec-edgar","filing":"0001209191-19-035126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119035126/doc4.xml","form_type":"4"}},{"id":3499052,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-06T17:01:06.000Z","date":"2019-06-04","kind":"sale","acquired":false,"shares":2852,"price":42.66,"value":121666.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":15175,"source":{"system":"sec-edgar","filing":"0001209191-19-035126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119035126/doc4.xml","form_type":"4"}},{"id":3499051,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-06T17:01:06.000Z","date":"2019-06-04","kind":"sale","acquired":false,"shares":2074,"price":42.91,"value":88995.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":18027,"source":{"system":"sec-edgar","filing":"0001209191-19-035126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119035126/doc4.xml","form_type":"4"}},{"id":3500763,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-05T16:21:48.000Z","date":"2019-06-03","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-034738","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119034738/doc4.xml","form_type":"4"}},{"id":3500762,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-05T16:21:48.000Z","date":"2019-06-03","kind":"exercise","acquired":false,"shares":3010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.52,"expiration_date":"2022-03-02","underlying":"Common Stock","underlying_shares":3010},"source":{"system":"sec-edgar","filing":"0001209191-19-034738","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119034738/doc4.xml","form_type":"4"}},{"id":3500761,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-05T16:21:48.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":15510,"price":43.21,"value":670187.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.14 to $43.49, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20101,"source":{"system":"sec-edgar","filing":"0001209191-19-034738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119034738/doc4.xml","form_type":"4"}},{"id":3500760,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-05T16:21:48.000Z","date":"2019-06-03","kind":"exercise","acquired":true,"shares":12500,"price":10.81,"value":135125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":35611,"source":{"system":"sec-edgar","filing":"0001209191-19-034738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119034738/doc4.xml","form_type":"4"}},{"id":3500759,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-05T16:21:48.000Z","date":"2019-06-03","kind":"exercise","acquired":true,"shares":3010,"price":10.52,"value":31665.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":23111,"source":{"system":"sec-edgar","filing":"0001209191-19-034738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919119034738/doc4.xml","form_type":"4"}},{"id":3892693,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T19:20:30.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the\nremaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in\ncontinuous service with the issuer as of each vesting date."}],"balance_after":47250,"derivative":{"exercise_price":38.35,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":47250},"source":{"system":"sec-edgar","filing":"0001209191-18-038202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919118038202/doc4.xml","form_type":"4"}},{"id":3892692,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-06-15T19:20:30.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2019, provided that the reporting person\nremains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one\nshare of the issuer's common stock."}],"balance_after":20101,"source":{"system":"sec-edgar","filing":"0001209191-18-038202","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919118038202/doc4.xml","form_type":"4"}},{"id":3903548,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-06-06T20:09:56.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":1367,"price":33.02,"value":45138.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":12226,"source":{"system":"sec-edgar","filing":"0001209191-18-036184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919118036184/doc4.xml","form_type":"4"}},{"id":3945676,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-04T18:51:28.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":34.375,"expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-028188","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919118028188/doc4.xml","form_type":"4"}},{"id":4279284,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-16T20:06:11.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":17500,"derivative":{"exercise_price":44.2,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-17-040683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919117040683/doc4.xml","form_type":"4"}},{"id":4279283,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":153880,"kind":"person","name":"Scranton Richard","position":1,"cik":"0001709330","reported_name":"Scranton Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-06-16T20:06:11.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":13593,"source":{"system":"sec-edgar","filing":"0001209191-17-040683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709330/000120919117040683/doc4.xml","form_type":"4"}}]}